mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.06 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.07 |
mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.07 |